Immunogenicity and safety of conjugate meningococcal group C vaccine in infants.

被引：0
|
作者：
Rennels, MB
Edwards, KM
Keyseding, HL
Reisinger, KS
Hogerman, DA
Kimura, A
Malinoski, FJ
机构：
[1] UNIV MARYLAND,DEPT PEDIAT,BALTIMORE,MD 21201
[2] VANDERBILT UNIV,DEPT PEDIAT,NASHVILLE,TN
[3] EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322
[4] PITTSBURGH PEDIAT,DEPT PEDIAT,PITTSBURGH,PA
[5] WYETH LEDERLE VACCINES & PEDIAT,DEPT PEDIAT,ROCHESTER,NY
来源：
PEDIATRIC RESEARCH | 1996年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1083 / 1083
页数：1
相关论文
共 50 条
  • [31] Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence
    Findlow, Jamie
    Knuf, Markus
    FUTURE MICROBIOLOGY, 2019, 14 (07) : 563 - 580
  • [32] Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain
    Diez-Domingo, Javier
    Gurtman, Alejandra
    Bernaola, Enrique
    Gimenez-Sanchez, Francisco
    Martinon-Torres, Federico
    Pineda-Solas, Valentin
    Delgado, Alfonso
    Infante-Marquez, Pilar
    Liang, John Z.
    Giardina, Peter C.
    Gruber, William C.
    Emini, Emilio A.
    Scott, Daniel A.
    VACCINE, 2013, 31 (46) : 5486 - 5494
  • [33] Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12-to 18-month-old children
    Noya, Francisco
    McCormack, Deirdre
    Reynolds, Donna L.
    Neame, Dion
    Oster, Philipp
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2014, 25 (04): : 211 - 216
  • [34] Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine
    Fu, Chuanxi
    Huang, Guihua
    Cui, Min
    Wang, Ming
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (01) : 138 - 139
  • [35] Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine
    Robertson, Corwin A.
    Greenberg, David P.
    Hedrick, James
    Pichichero, Michael
    Decker, Michael D.
    Saunders, Martha
    VACCINE, 2016, 34 (44) : 5273 - 5278
  • [36] Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
    Bermal, Nancy
    Huang, Li-Min
    Dubey, A. P.
    Jain, Hermant
    Bavdekar, Ashish
    Lin, Tzou-Yien
    Bianco, Veronique
    Baine, Yaela
    Miller, Jacqueline M.
    HUMAN VACCINES, 2011, 7 (02): : 239 - 247
  • [37] Meningococcal group C conjugate vaccine: benefits exceed risks
    Reactions Weekly, 2000, 818 (1) : 2 - 2
  • [38] Meningococcal vaccine group C conjugate (Wyeth-Lederle).
    不详
    Drugs in R & D, 1999, 2 (3) : 213 - 214
  • [39] Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine
    Findlow, Jamie
    Findlow, Helen
    Frankland, Sarah
    Holland, Ann
    Holme, Daniel
    Newton, Emma
    Southern, Jo
    Waight, Pauline
    Kaczmarski, Ed
    Miller, Elizabeth
    Borrow, Ray
    JOURNAL OF OCCUPATIONAL MEDICINE AND TOXICOLOGY, 2014, 9
  • [40] Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid
    Silveira, I. A. F. B.
    Bastos, R. C.
    Neto, M. S.
    Laranjeira, A. P.
    Assis, E. F.
    Fernandes, S. A. R.
    Leal, M. L.
    Silva, W. C.
    Lee, C.-H.
    Frasch, C. E.
    Peralta, J. M.
    Jessouroun, E.
    VACCINE, 2007, 25 (41) : 7261 - 7270
12345